Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
|ClinicalTrials.gov Identifier: NCT01821053|
Recruitment Status : Completed
First Posted : March 29, 2013
Last Update Posted : October 16, 2015
|Condition or disease|
|Preeclampsia Type 1 Diabetes|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||85 participants|
|Official Title:||Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus|
|Study Start Date :||June 2013|
|Actual Primary Completion Date :||September 2015|
|Actual Study Completion Date :||October 2015|
pregestational type 1 diabetes
It is an observational study. No intervention is made.
- preeclampsia [ Time Frame: 3 years ]The development of preeclampsia, defined by hypertension ( > 140/90 mmHg) and proteinuria ( >0,3 g/24 hour).
- preterm delivery [ Time Frame: 3 years ]post-partum registration of preterm delivery
- light for gestational age [ Time Frame: 3 years ]post-partum registration of "light for gestational age"
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01821053
|Gynelogical Obstetrical Department|
|Skejby, Aarhus N, Denmark, 8200|
|Study Director:||Boye L. Jensen, Professor||cardiovascular and renal research department, Odense University Hospital|